1. |
Liu XX, Yuan L, Chen F, et al. Circulating miR-208b: a potentially sensitive and reliable biomarker for the diagnosis and prognosis of acute myocardial infarction. Clin Lab, 2017, 63(1): 101-109.
|
2. |
Hsu JT, Chung CM, Chu CM, et al. Predictors of left ventricle remodeling: combined plasma B-type natriuretic peptide decreasing ratio and peak creatine kinase-MB. Int J Med Sci, 2017, 14(1): 75-85.
|
3. |
Lin JF, Hsu SY, Teng MS, et al. Activin a predicts left ventricular remodeling and mortality in patients with ST-Elevation myocardial infarction. Acta Cardiol Sin, 2016, 32(4): 420-427.
|
4. |
Nägele MP. Letter by nägele regarding article, " effect of omega-3 acid ethyl esters on left ventricular remodeling after acute myocardial infarction: the OMEGA-REMODEL randomized clinical trial”. Circulation, 2017, 135(2): e11-e12.
|
5. |
Reichert K, Pereira do Carmo HR, Galluce Torina A, et al. Atorvastatin improves ventricular remodeling after myocardial infarction by interfering with collagen metabolism. PLoS One, 2016, 11(11): e0166845.
|
6. |
Mccarty MF. Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate. Med Hypotheses, 1996, 46(2): 89-100.
|
7. |
Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol, 2009, 53(15): e1-e90.
|
8. |
Sadek MM, Haddad T, Haddad H. The role of statins in chronic heart failure. Curr Opin Cardiol, 2009, 24(2): 167-171.
|
9. |
Yang YJ, Zhang YE, Liu XY, et al. Exogenous taurine attenuates mitochondrial oxidative stress and endoplasmic reticulum stress in rat cardiomyocytes. Acta Biochim Biophys Sin (Shanghai), 2013, 45(5): 359-367.
|
10. |
Zulli A. Taurine in cardiovascular disease. Curr Opin Clin Nutr Metab Care, 2011, 14(1): 57-60.
|
11. |
Schaffer SW, Jong CJ, Ito T, et al. Effect of taurine on ischemia-reperfusion injury. Amino Acids, 2014, 46(1): 21-30.
|
12. |
Pansani MC, Azevedo PS, Rafacho BP, et al. Atrophic cardiac remodeling induced by taurine deficiency in wistar rats. PLoS One, 2012, 7(7): e41439.
|
13. |
贵州省科学技术委员会. 黔科条通宇(1993)第 25 号 关于发布《贵州省实验动物管理实施细则》的通知. (1993-04-20)[2015-06-01]. http://dwzx.gmc.edu.cn/info/1377/2544.htm.
|
14. |
刘蜜, 王琛, 王晓礽, 等. 西洋参茎叶总皂苷通过抑制内质网应激相关细胞凋亡减轻大鼠急性心肌梗死后心室重构. 中国病理生理杂志, 2013, 29(5): 796-803.
|
15. |
Litwin SE, Katz SE, Morgan JP, et al. Serial echocardiographic assessment of left-ventricular geometry and function after large myocardial infarction in the rat. Circulation, 1994, 89(1): 345-354.
|
16. |
Tang XL, Sanganalmath SK, Sato H, et al. Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. PLoS One, 2011, 6(9): e25320.
|
17. |
Bendall JK, Damy T, Ratajczak P, et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation, 2004, 110(16): 2368-2375.
|
18. |
Miyamoto TA, Ueno T, Iguro Y, et al. Taurine-mediated cardioprotection is greater when administered upon reperfusion than prior toischemia. Adv Exp Med Biol, 2009, 643: 27-36.
|
19. |
Sahin MA, Yucel O, Guler A, et al. Is there any cardioprotective role of taurine during cold ischemic period following global myocardial ischemia?. J Cardiothorac Surg, 2011, 6: 31.
|
20. |
Xu YJ, Saini HK, Zhang M, et al. MAPK activation and apoptotic alterations in hearts subjected to calcium paradox are attenuated by taurine. Cardiovasc Res, 2006, 72(1): 163-174.
|
21. |
孙凌, 杨吉成, 袁志昌, 等. 牛磺酸抑制新生大鼠心肌重塑的体外研究. 江苏医药, 2004, 30(2): 81-83.
|